Dublin, March 23, 2022 (GLOBE NEWSWIRE) -- The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis - 2022 to 2026 " report has been added to ResearchAndMarkets.com's offering.
The COVID Pandemic has created a surge in Whole Genome Sequencing of Pathogens but cancer related activity has suffered. Find out all about it in the comprehensive report of Whole Genome Sequencing. The complete genome of the COVID virus is included as an example of the work being done.
Will all newborns receive Whole Genome Sequencing at birth? How fast will Direct to Consumer Testing grow? What sequencing technology will take the lead? What's holding the industry back? Where are the over 800 locations that have high throughput devices?
Ourfacts and support =Your success.
A plummeting of costs for Whole Genome Sequencing is creating a gold rush for market players. New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well funded players is racing for market share on a truly global stage.
Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
This research will make you the expert in your organization. Get the research team working for you by ordering all, or a portion, of this comprehensive report. All report data is available in Excel format on request. Make investment decisions and valuations with confidence using the latest data.
The report includes five year market forecasts and detailed breakouts for 14 countries and 5 regions.
WGES Recent Developments
- GenomSys Gains CE Mark for New Genomic Analysis Software
- WGS Finds Lung Cancers Fall Into Molecular Subtypes
- Testing Distinguishes Benign Tumors From Precancerous Condition
- Plan to Sequence All Newborns in UK
- Clear Labs Raises $60M for Nanopore Sequencing
- Variantyx Expands Into Prenatal, Cancer Testing
- Whole-Genome Sequencing Aids Diagnosis in Stockholm
- Variantyx Raises $20M
- Nonacus WGS Service for SARS-CoV-2 Laboratories
- Center to Report Risk Scores in Clinical WGS
- Stanford Launches WGS for Cardiovascular Testing
- Illumina and NY Healthcare Partner on Clinical WGS
- Increased Adoption of WGS Needs Acceptance by Payors, Providers
- Veritas Intercontinental Completes €5M Series B Financing Round
- M2GEN and Discovery Life Sciences in Bioinformatics Agreement
- Genomics England Adopts Quantum ActiveScale Object Storage
- GenomiQa, Icon Group to Validate Genomic Analysis Platform CapeDx
- NHS Wales Introduces WGS for Critically Ill Newborns
- Illumina Achieves EAU for NGS-Based SARS-CoV-2 Test
- C2i Genomics to Launch Trials for MRD Detection Tech
- Roche Acquires Sequencing Company Stratos Genomics
- UK COVID-19 Sequencing Consortium Launches
- Invitae Acquires Three Companies: YouScript, Genelex, Diploid
- Experience From Centralized Genomic Medicine Lab
- MGI to Enable $100 Human Genome
- Nebula Genomics offers $299 WGS
- Team to Study Campylobacter Omics
- Veritas Genetics Restarts US Business
- NEOGEN, Gencove partner to advance animal genomics
- UK Whole-Genome Sequencing Project Obtains £200M
- WGS may help with disease outbreaks
- Veritas Cuts WGS Price by 40%
- Dante Labs Launches GenomeL, Long Reads Human Whole Genome Sequencing
- Machine-learning system used to diagnose genetic diseases
- Whole Genome Sequencing for healthy creates controversy
- Nebula Genomics Offers FREE Whole Genome Sequencing
Key Topics Covered:
Market Guides
- Whole Genome Sequencing Market - Strategic Situation Analysis & COVID Impact
- Selected Genetic Testing Companies Revenue & Growth
- Selected Companies Growth Chart
- Guide for Executives, Marketing, Sales and Business Development Staff
- Guide for Management Consultants and Investment Advisors
Market Overview
Whole Genome Sequencing - Markets, Examples and Discussion
Direct to Consumer - Two Approaches
- The New Age of Medical Information
- Dangers in DTC-WGS - Health Costs and Regulation
- Newborn and Prenatal - A Brave New World
- DTC - How Many Segments?
Research Markets
- Research Funding and Capital Expense
- WGS Datasets Preferred
- Existing research repurposed
- Organism Wide Market
- Service Suppliers Respond
- Clinical - Understanding Germline and Somatic
- Somatic - Chasing Mutations and Pharmacogenomics
- Pathogen Testing
- The Hepatitis C Story
- Will the Microbiology Department Disappear?
- AgriBio - Big Business
- GMO is Here to Stay
- WGS Benefits and Risks
- The New Agriculture
Industry Structure
- Hospital's Testing Share
- Economies of Scale
- Instrument Manufacturer Role
- Healthcare Industry Impacts - Still Struggling
- Can the Healthcare Industry Adapt?
- Genetic Counselling as an Industry
- WGES Adoption and Cannibalization
- The Meaning of Grail
Market Trends
Factors Driving Growth
- Diagnostic Factors
- Interpreting the Code Otherwise
- Changes in Agriculture
- Fertility Technology Comes of Age
- Pathogen Challenges
Factors Limiting Growth
- Increased Competition Lowers Price
- Lower Costs
- Healthcare Cost Concerns Curtail Growth
- Wellness has a downside
- GMO Opposition Movement
Sequencing Instrumentation
- Instrumentation Tenacity
- Declining Cost Changes Industry Structure
- llumina
- ION
- Pacific Biosystems
- Roche 454
- SOLiD
- Oxford Nanopore
- Long Reads - Further Segmentation
- Linked Reads
- Targeted Sequencing Adopts CRISPR
New Sequencing Technologies
- RNAP sequencing
- In vitro virus high-throughput sequencing
- Tunnelling currents DNA sequencing
- Sequencing by hybridization
- Sequencing with mass spectrometry
- Microfluidic Sanger sequencing
- Microscopy-based techniques
Profiles of Key Companies
- 10x Genomics, Inc.
- 23andME Inc.
- Abbott Diagnostics
- AccuraGen Inc.
- Adaptive Biotechnologies
- Admera Health, LLC
- Agena Bioscience, Inc.
- Agilent
- Akonni Biosystems
- Ancestry.com LLC
- Anchor Dx
- ArcherDx, Inc.
- ARUP Laboratories
- Asuragen
- Baylor Miraca Genetics Laboratories
- Beckman Coulter Diagnostics
- Becton, Dickinson and Company
- BGI Genomics Co. Ltd
- Bioarray Genetics
- Biocept, Inc.
- Biodesix Inc.
- BioFluidica
- BioGenex
- Biolidics Ltd
- bioMerieux Diagnostics
- Bioneer Corporation
- Bio-Rad Laboratories, Inc
- Bio-Techne
- C2i Genomics
- Cancer Genetics
- Caris Molecular Diagnostics
- CellMax Life
- Centogene
- Chronix Biomedical
- Circulogene
- Clear Labs
- Clinical Genomics
- Complete Genomics, Inc. - A BGI Company
- Cynvenio
- Dante Labs
- Datar Cancer Genetics Limited
- Day Zero Diagnostics
- Diasorin S.p.A.
- Epic Sciences
- Epigenomics AG.
- Eurofins Scientific
- Excellerate Bioscience
- Exosome Diagnostics
- Fabric Genomics
- Fluidigm Corp
- Freenome
- FUJIFILM Wako Diagnostics
- Fujirebio
- Fulgent Genetics
- GE Global Research
- GE Healthcare Life Sciences
- Gencove
- Genedrive
- GeneFirst Ltd.
- Genetron Health (Beijing) Co., Ltd.
- Genewiz
- Genomic Health
- Genomics England
- Genomics Personalized Health (GPH)
- GenomOncology
- Genzyme Corporation
- Grail, Inc.
- Grifols
- Guardant Health
- Guardiome
- HeiScreen
- Helix
- Helomics
- Hologic
- Horizon Discovery
- HTG Molecular Diagnostics
- Human Longevity, Inc.
- iCellate
- Illumina
- Incell Dx
- Inivata
- Invitae Corporation
- Invivoscribe
- Karius
- Macrogen
- MDNA Life SCIENCES, Inc.
- MDx Health
- Medgenome
- Meridian Bioscience
- Mesa Biotech
- MIODx
- miR Scientific
- MNG Labs
- Molecular MD
- NantHealth, Inc.
- Natera
- Nebula Genomics
- NeoGenomics
- New Oncology
- Novogene Bioinformatics Technology Co., Ltd.
- Omega Bioservices
- OncoDNA
- OpGen
- ORIG3N, Inc.
- Origene Technologies
- Oxford Nanopore Technologies
- Panagene
- Perkin Elmer
- Personal Genome Diagnostics
- Personalis
- Precipio
- PrecisionMed
- Promega
- Protagen Diagnostics
- Qiagen Gmbh
- Quantumdx
- Regeneron
- Roche Molecular Diagnostics
- Roswell Biotechnologies
- Seegene
- Sequencing.com
- Siemens Healthineers
- simfo GmbH
- Singlera Genomics Inc.
- SkylineDx
- Stratos Genomics
- Sure Genomics, Inc.
- Sysmex
- Sysmex Inostics
- Tempus Labs, Inc.
- Thermo Fisher Scientific Inc.
- Veritas Genetics
- Volition
For more information about this report visit https://www.researchandmarkets.com/r/xtzrzx
